Options
Title
Lipid based biomarker for the multiple sclerosis
Date Issued
2019
Author(s)
Patent No
3467505
Abstract
The present invention relates to a method for diagnosing multiple sclerosis (MS) in a subject suspected to suffer therefrom comprising the steps of: a) determining the amounts of at least three markers from a group of markers comprising LPA20.4, HETE15S (15-hydroxyeicosatetranoic acid), GluCerC16, LacCerC24.1, C16Sphinganine, biopterin, PEA (palmitoylethanolamine) and OEA (oleoylethanolamide) in a sample of said subject; b) comparing the determined amounts to a reference or to references; and c) diagnosing MS based on said comparison in said subject.
Language
en
Patenprio
EP 3467505 A1: 20171004